Profile
Sonny Hsiao is the founder.
Dr. Hsiao is the founder of Acepodia, Inc. and holds the title of President, Chief Executive Officer, Director & GM since 2017.
Dr. Hsiao is the founder of Acepodia Biotechnologies, Ltd. and holds the title of Chief Executive Officer & Chief Scientific Officer since 2017.
Dr. Hsiao is the founder of Acepodia, Inc. (United States) and holds the title of President, CEO, CSO & Director since 2017.
Dr. Hsiao is also the founder of Adheren Biologics, Inc. Dr. Hsiao's education history includes an undergraduate degree from National Taiwan University and a doctorate from the University of California.
Sonny Hsiao active positions
| Companies | Position | Start |
|---|---|---|
| ACEPODIA, INC. | Founder | 2017-02-14 |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Develops novel, targeted, allogeneic cell therapies to treat cancers | Chief Executive Officer | 2016-12-31 |
Former positions of Sonny Hsiao
| Companies | Position | End |
|---|---|---|
Adheren Biologics, Inc.
Adheren Biologics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focusing on cancer immunotherapy | Chief Executive Officer | - |
Education of Sonny Hsiao
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adheren Biologics, Inc.
Adheren Biologics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focusing on cancer immunotherapy | Health Technology |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Develops novel, targeted, allogeneic cell therapies to treat cancers | Health Technology |
Acepodia, Inc.
Acepodia, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops cell therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Sonny Hsiao
















